TEVA-MOMETASONE
TEVA-MOMETASONE
Approved
DIN Number
02248130
Drug Class
Human
Market Date
Nov 4, 2003
Company
HC
teva canada limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02248130
AIG Number0121732001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D07AC13 MOMETASONE
Product Specifications
Dosage FormOintment
Route of AdministrationTopical
AHFS Classification84:06.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
MOMETASONE FUROATEActive
Strength: 0.1 %
Monograph: MOMETASONE FUROATE